Maternal metabolic disturbances such as obesity and type 2 diabetes mellitus (T2DM) are associated with decreased fetal growth early in pregnancy, followed by a catch-up growth (5, 6), suggesting a central role of the maternal glucose-insulin axis in the metabolic and endocrine adaptations required for a healthy pregnancy. The gene discussed is INS; the disease is obesity disorder.